Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
Childs Nerv Syst. 2023 Aug;39(8):2079-2086. doi: 10.1007/s00381-023-05917-0. Epub 2023 Mar 23.
The perioperative treatment of hydrocephalus in pediatric posterior fossa tumors with an external ventricular drain (EVD) is the treatment of choice in our center. We analyzed our experience in using EVD concerning safety and effectivity.
This is a single-center retrospective cohort study of 100 consecutive pediatric patients who underwent resection for a newly diagnosed tumor in the posterior fossa between 2011 and 2022.
Of the 100 patients with posterior fossa tumors, 80 patients (80%) had radiological signs of hydrocephalus at presentation, 49 patients (49%) of whom underwent placement of an EVD. In 40 patients, the EVD was inserted at a mean of 2.25 days prior to the tumor resection; 9 had the EVD inserted during tumor resection (frontal trajectory in 7 patients, occipital trajectory in 2 patients). Histology revealed pilocytic astrocytoma in 48 patients, medulloblastoma in 32, ependymoma in 11, and other histologic entities in 9 patients. Gross total/near-total resection was achieved in 46 (95.83%) of the 48 pilocytic astrocytomas, 30 (93.75%) of the 32 medulloblastomas, and 11 (100%) of the 11 ependymomas. The mean number of total days with the EVD in place was 8.61 ± 3.82 (range 2-16 days). The mean number of days with an EVD after tumor resection was 6.35 ± 3.8 (range 0-16 days). EVD-associated complications were seen in 6 patients (12.24%) including one infection. None of these resulted in a worse clinical course or any long-term sequelae. Permanent CSF diversion at 6 months after surgery was necessary in 13 patients (13%), including two VP shunt, two SD-shunt, six endoscopic third ventriculostomy (ETV), and three combined VP shunt and ETV procedures. Patients with a medulloblastoma or ependymoma had a higher rate of permanent CSF diversion needed than the group of pilocytic astrocytoma patients (27.9% versus 2.13%, p < 0.001). In patients with metastatic disease, 7 of 17 patients (41.18%) needed a permanent CSF diversion, compared to 6 of 83 patients (7.23%) in the group without metastasis (p = 0.001).
The treatment of hydrocephalus in pediatric posterior fossa tumors with an EVD as a temporary measure is safe and effective, provided that a multi-professional understanding for its handling is given and there is no need for a long transport of the children.
在本中心,对于伴有脑室外引流(EVD)的小儿后颅窝肿瘤患者,围手术期脑积水的治疗是首选方法。我们分析了使用 EVD 的安全性和效果。
这是一项回顾性单中心队列研究,纳入了 2011 年至 2022 年间在本中心接受新诊断的后颅窝肿瘤切除术的 100 例连续患儿。
在 100 例后颅窝肿瘤患儿中,80 例(80%)在就诊时存在脑积水的影像学表现,其中 49 例(49%)接受了 EVD 放置。40 例患儿在肿瘤切除前平均 2.25 天放置 EVD;9 例在肿瘤切除期间放置 EVD(7 例为额部入路,2 例为枕部入路)。组织学显示毛细胞型星形细胞瘤 48 例,髓母细胞瘤 32 例,室管膜瘤 11 例,其他组织学实体瘤 9 例。48 例毛细胞型星形细胞瘤中,46 例(95.83%)达到大体全切除/近全切除,32 例髓母细胞瘤中,30 例(93.75%)达到大体全切除/近全切除,11 例室管膜瘤中,11 例(100%)达到大体全切除/近全切除。EVD 留置总天数的平均值为 8.61±3.82 天(范围 2-16 天)。肿瘤切除后 EVD 留置天数的平均值为 6.35±3.8 天(范围 0-16 天)。EVD 相关并发症见于 6 例患儿(12.24%),包括 1 例感染。没有一例导致更差的临床病程或任何长期后遗症。术后 6 个月需要永久性脑脊液分流的患儿有 13 例(13%),包括 2 例脑室-心房分流术,2 例皮下分流术,6 例内镜第三脑室造瘘术(ETV)和 3 例脑室-心房分流术和 ETV 联合手术。髓母细胞瘤或室管膜瘤患儿需要永久性脑脊液分流的比例高于毛细胞型星形细胞瘤患儿(27.9%比 2.13%,p<0.001)。在患有转移性疾病的患儿中,17 例患儿中有 7 例(41.18%)需要永久性脑脊液分流,而在无转移的 83 例患儿中,有 6 例(7.23%)需要永久性脑脊液分流(p=0.001)。
在后颅窝肿瘤患儿中,EVD 作为一种临时措施治疗脑积水是安全有效的,前提是多学科团队理解其处理方法,并且患儿不需要长途运输。